| Name | Title | Contact Details |
|---|
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
Bosley is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Good360 is a Alexandria, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established as a non-profit organization in 1995, the Upper Chesapeake Health Foundation is dedicated to supporting UCH and its vision to create the healthiest community in Maryland. The funds raised are managed in accordance with donor wishes,
NuWave is a Upland, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.